Metformin improves prostate cancer-specific survival and inhibits the development of castrate resistant metastasis Meeting Abstract


Authors: Spratt, D.; Zhang, C.; Zumsteg, Z. S.; Pei, X.; Zhang, Z.; Yamada, J.; Kollmeier, M.; Cox, B.; Zelefsky, M. J.
Abstract Title: Metformin improves prostate cancer-specific survival and inhibits the development of castrate resistant metastasis
Meeting Title: 54th Annual Meeting of the American Society for Radiation Oncology (ASTRO)
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 84
Issue: 3 Suppl.
Meeting Dates: 2012 Oct 28-31
Meeting Location: Boston, MA
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2012-11-01
Start Page: S93
Language: English
ACCESSION: WOS:000310542900230
PROVIDER: wos
DOI: 10.1016/j.ijrobp.2012.07.243
Notes: Meeting Abstract: 228 - 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) - OCT 28-31, 2012 - Boston, MA - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Zhigang Zhang
    427 Zhang
  2. Brett Wayne Cox
    63 Cox
  3. Michael J Zelefsky
    754 Zelefsky
  4. Yoshiya Yamada
    479 Yamada
  5. Marisa A Kollmeier
    227 Kollmeier
  6. Zachary Stephan Zumsteg
    36 Zumsteg
  7. Daniel Eidelberg Spratt
    77 Spratt
  8. Xin Pei
    134 Pei
  9. Chi Zhang
    1 Zhang